Racial Differences in Vagal Control of Glucose Homeostasis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 5, 2017

Study Completion Date

October 5, 2017

Conditions
Obesity
Interventions
DRUG

Galantamine

16 mg po prior to the infusion of intralipid

DRUG

Placebo Oral Capsule

Placebo oral capsule prior to the infusion of intralipid/heparin

DRUG

Intralipid

Intralipid 20% will be infused at 0.8 mL/m2/min for 4h after oral placebo or Galantamine

DRUG

Heparin

heparin bolus of 1000 U will be followed by 200 U/h infusion for 4h after oral placebo or Galantamine

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

Doris Duke Charitable Foundation

OTHER

lead

Vanderbilt University Medical Center

OTHER

NCT02365285 - Racial Differences in Vagal Control of Glucose Homeostasis | Biotech Hunter | Biotech Hunter